Abstract: A series of sila-organosulphur compounds containing 1,2,3-triazole cores were screened for their cytotoxic activity on human breast cancer cell line MCF-7. Most of the tested compounds exhibited moderate-to-good activity against the cancer cells. Especially, the compound 4-((2-(trimethylsilyl)ethynylthio)methyl)-1-benzyl-1H-1,2,3-triazole (3a) from series of sila-substituted thioalkyne 1,2,3-triazoles (STATs) and the compounds 3-(1-benzyl-1H-1,2,3-triazol-4-yl)-1-mercapto-1,1-bis(trimethylsilyl)propane-2-thione (4a) and 1-mercapto-1,1-bis(trimethylsilyl)-3-(1-phenethyl-1H-1,2,3-triazol-4-yl)propane-2-thione (4e) from series of sila-substituted mercapto-thione 1,2,3-triazoles (SMTTs) exhibited promising cytotoxicity against MCF-7 with IC 50 values of 35.17, 32.63 and 30.3 lg/mL, respectively. In addition, the possible mechanisms for inhibition of cell growth and induction of apoptotic cell death were explored by DAPI staining, cell cycle analysis and qRT-PCR. The synthetic compounds were evaluated for their in vitro antibacterial activities, and as a result, the most prominent effects were observed for 3e and 4e. Especially, 3e was found to be quite active against all the tested strains with the MIC values ranging from 15 to 62 lg/mL, except P. aeruginosa. The results of the time-kill assay suggested that the compound of 3e completely inhibited the growth of both gram-negative bacteria, A. baumannii, and gram-positive bacteria, S. aureus. In addition, SEM analysis confirmed morphostructural damage of the bacteria. Our findings could be applicable for developing dual-targeting anticancer/antibacterial therapeutics.
The study of the relationship between chemical structure and the activity of chemical compounds helps in perceiving the mechanism of bioactivity and provides a tool to predict efficiency of new compounds based on information of the structural parameters in order to discover and design novel potent agents for treating different diseases [1] .
The incorporation of organosilicon moieties into drug structures provides a new and potent source of chemical diversity in designing drugs with low toxicity, high stability under physiological conditions, high lipophilicity and high permeability of a molecule [2, 3] . Organosilicon compounds of nitrogen and sulphur containing ligands have received much attention recently due to their biological importance such as anticarcinogenic, antibacterial, tuberculostatic, antifungal, insecticidal and acaricidal activities [4, 5] . A number of silasubstituted drugs such as cyclohexyl(phenyl)(3-piperidin-1-yl) propyl)silanol and sila-derived phthalocyanine have revealed favourable results in photodynamic cancer treatment [6, 7] . Additionally, silperisone [6] , Tac101 [8] and BNP1350 [7] drugs based on silicon scaffold have entered clinical trials.
The modification of organosilicon compounds with pharmacophore organic framework has contributed to the prosperity of bio-organometallic chemistry.
Meanwhile, 1,2,3-triazoles, as an important class of aromatic heterocycles, show a variety of biological activities such as antibacterial [9, 10] , antifungal [11, 12] , anti-inflammatory and antitubercular activities [13] , as well as anti-HIV activity [14] . The 1,2,3-triazoles are easily formed by click chemistry reaction [15] . These heterocyclic compounds are stable to acid and basic hydrolysis and reductive and oxidative conditions. In addition, high dipole moment and active participation in hydrogen-bond formation help them in binding easily with the biological targets [16] . A number of drugs with 1,2,3-triazole cores such as tazobactam [17] , cefatrizine [18] and carboxyamidotriazole [19] are used in medicinal chemistry. Additionally, many investigations showed that structural modification of the triazole scaffolds with various substituents could affect the interactions of triazoles with cells and tissues. For example, modulation of the triazole ring with the sulphur group as an electron-rich centre improved lipophilicity and accelerated their diffusion on the lipid layer of the microorganism membranes. It was also proposed that the organosulphur groups might inhibit enzyme synthesis through linking with definite cell site of action of an enzyme [20] [21] [22] .
Having considered the above-mentioned facts and the importance of biologically active organosulphur groups, 1,2,3-triazole aromatic heterocycles, and the organosilicon compounds, we became encouraged to investigate their potential synergistic effect on the same molecule. We have recently reported a series of novel sila-substituted organosulphur compounds based on 1,2,3-triazole scaffold [23] . The study of new families of organometallic compounds such as sila-thioalkyne 1,2,3-triazoles (STATs) and sila-mercaptothione 1,2,3-triazoles (SMTTs) comprises an unexplored field of research. Herein, for the first time, the growth inhibitory effects of sila-substituted thioalkyne and mercapto-thione compounds containing 1,2,3-triazole moieties on human breast cancer (MCF-7) cell line, gram-positive and gram-negative bacterial cells were reported. Our findings may help in designing novel drugs with a potential for reducing the risk of bacterial infections along with antitumour effects in the cancer patients whose immune system is at high risk of developing invasive bacterial infections.
Materials and Methods
Chemicals were either prepared in our laboratory or obtained from Merck, Fluka and Aldrich. Melting points were measured with an Electro thermal melting point tool. The 1 H and
13
C NMR spectra were measured on Bruker FT-400 MHz spectrometer at room temperature and with CDCl 3 as solvent. The FT-IR spectra were recorded on a Bruker Tensor 270 spectrometer. Elemental analyses were carried out with an Elementar Vario EL III apparatus.
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), 4 0 ,6-diamidino-2-phenylindole (DAPI) and other biological components were obtained from Invitrogen (Carlsbad, CA, USA). Doxorubicin hydrochloride (DOX) was purchased from Zhejiang Hisun Pharmaceutical Co., Ltd., Taizhou, China. Mueller-Hinton broth and nutrient agar were purchased from Merck and used as a microbial growth media. The following bacteria were used for the experiment: P. aeruginosa (ATCC 27853), S. aureus (ATCC 29737), A. baumannii (PTCC 1855), E. faecium (ATCC 8459) and E. faecalis (ATCC 29212).
Preparation of source cell. The breast cancer cell line MCF-7 obtained from the Iranian Cell Bank located in the Pasteur Institute of Iran, Tehran, was used for cytotoxicity and biological assays. For preparing cell source, MCF-7 cells were grown on the RPMI 1640 medium (Bioidea, Iran) and foetal bovine serum (FBS) in a ratio of 10:100. Streptomycin (Bioidea) (100 lg/mL) and penicillin (Bioidea) (100 U/mL) were employed in the culture medium. Incubation was performed at 37°C, wet, 5% CO 2 . Media were exchanged with fresh ones every 3 days.
Colorimetric viability test. The cytotoxicity of the synthesized silasubstituted thioalkyne and mercapto-thione containing 1,2,3-triazoles (3a-i and 4a-i) was determined using the MTT (3-(4,5-dimethyl-2-yl)-2,5-diphenyl tetrazolium bromide) assay. The tested compounds were dissolved in DMSO and then diluted with cultivation media according to certain concentrations. Doxorubicin was used as the positive control. The previous protocols were employed in MTT assay [24] [25] [26] . The cells were seeded in 96-well plates and a density of 5 9 10 3 cells per well was employed. The cells were allowed to experience one-day incubation period to attach at 37°C and 5% CO 2 . The media was removed and the concentrations (0, 5, 10, 20, 30, 60, 100, 150, 200, 300, 400 and 500 lg/mL) of the tested compounds were administered to the seeded cells. The routine medium containing 1% DMSO was set for control. After 48 hr, the upper media were replaced with 200 lL of 2 mg/mL of the MTT (Sigma) and further incubated for 4 hr at 37°C. Finally, the media containing MTT was removed and 200 lL DMSO was added to each well to dissolve the metabolized crystallized formazan. The optical density (OD) was determined at 570 nm using spectrophotometric plate reader (Stat Fax 3200; Awareness Technology Inc.).
Flow cytometric analysis. For further evaluation of the cell cycle distributions in MCF-7 population, the cells were seeded in 6-well plates at a density of 5 9 10 5 cells/well and allowed for attaching overnight. At treatment stage, IC 50 concentrations of the compounds 3a, 4a and 4e were presented. After 48-hr incubation, the cells were trypsinized and collected. Next, they were washed with phosphatebuffered saline (PBS) and fixed with cold ethanol (70%) at 4°C for 2 days [27] . Then, they were washed with PBS, treated with ribonuclease A (Cinaclon, Iran) and stained with propidium iodide (Sigma) and located in a dark place at ambient temperature for 30 min. Cell population in 4 phases of eukaryotic cell cycle was analysed by means of flowcytometer (FACSCalibur, USA).
Analysis of cellular apoptosis. MCF-7 cells were cultured at a density of 5 9 10 5 cells per well in 6-well plates and incubated at 37°C, for 24 hr. Then, the cells were treated with compounds 3a, 4a, 4e and DOX at their IC 50 concentration. After 24 hr of treatment and removal of the supernatant, the cells were washed with PBS and fixed in 4% paraformaldehyde for 10 min. Permeabilization of the cells was carried out with permeabilizing buffer (3% paraformaldehyde and 0.5% Triton X-100) for 15 min., so that the cells allowed the stain to enter. After that, the cells were stained with DAPI (Sigma), retained for 10 min. in dark and then washed twice with PBS. Finally, pellets resuspended in 500 lL PBS and the morphology of nuclei was observed using a fluorescence microscopy (Olympus IX81, Germany). The condensed and fragmented nuclei were detected in the apoptotic cells [28] .
Real-time quantitative PCR (RT-PCR). MCF-7 cells (5 9 10
5 cells in each well) were pre-seeded in 6-well format and then treated with the test compounds 3a, 4a and 4e at their IC 50 concentration. The protocol for qRT-PCR was used as described in previous reports [27, [29] [30] [31] [32] . In brief, after 48-hr incubation, total RNA of the cells in exponential growth was extracted using TRIzol solution (Thermo Scientific) according to the manufacturer's procedure. Concentration of total RNA was determined using a Nano Drop spectrophotometer (Thermo Fisher Scientific 5225 Verona, NanoDrop One) by absorbance measuring at wavelengths of 260/280 nm. The cDNA was prepared using total RNA from each sample (1 lg), and oligo(dT) primers (1 lL) (Thermo Scientific) and other components of RevertAid cDNA synthesis kit (Thermo Scientific) were mixed according to the instructions of the manufacturer.
Real-time PCR was carried out in a Mic PCR system (Bio Molecular Systems, Mic) using SYBR Green Master Mix (Thermo Scientific) and by applying specific primers including Bcl-2, cyclin D1 and beta- (table 1) . Beta-actin housekeeping gene was applied for standardization of tested compounds mRNA expression. A total PCR mixture (20 lL) was prepared using cDNA (2 lL), forward primer (0.5 lL), reverse primer (0.5 lL), SYBR Green Master Mix (10 lL) and PCR-grade water (7 lL). Real-time PCR was performed according to the thermal profile at 95°C for 10 min., continued with 40 cycles, 95°C for 15 sec., 58°C for 30 sec. and 72°C for 30 sec. Relative levels of gene expression were evaluated using the 2
ÀDDCt method.
Antibacterial assays. The minimum inhibitory concentrations (MICs) of several antimicrobial agents such as STATs (3a-i) and SMTTs (4a-i) were determined by the broth microdilution method [33] . Overnight cultures of bacterial strains were used to prepare a suspension equal to 0.5 McFarland standard (1.5 9 10 8 CFU/mL). These bacteria include P. aeruginosa, S. aureus, A. baumannii, E. faecium and E. faecalis. The required concentrations (500, 250, 125, 62.5, 31.25, 15.62, 7.8 lg/mL) of the compound were dissolved in DMSO (1%) and diluted to give serial twofold dilutions. The suspensions of bacterial strains were then exposed to several dilutions of antimicrobial agents. Medium with DMSO, without tested compounds was included in each test. The contents of the tube were subcultured on Mueller-Hinton agar (MHA) plates and incubated for 24 hr at 37°C. Finally, the MIC value was recorded as the lowest concentration of the compound inhibiting the test bacterial growth on the agar plate.
Time-kill assay. Time-kill assays were processed according to the Clinical and Laboratory Standards Institute (CLSI) guidelines [34] . The bacterial cultures of gram-negative A. baumannii and grampositive S. aureus were prepared following the same procedure in the MIC assays introduced above. Then, the bacterial cultures were exposed to the tested compounds in the concentration equivalent to MIC and 29 MIC (lg/mL). Also, the bacterial strain without the test compound was used as the positive control in each trial. The samples were incubated on shaker incubator at 100 rpm and 37°C. At the selected time intervals 0, 30, 90, 180 and 240 min., 6-, 8-and 12-hr samples from the test culture were taken and serial dilutions were prepared in normal saline as needed. Then, 100 lL from each of the dilution was placed on a MHA plate in triplicates and incubated for 48 hr at 37°C. Finally, the visible bacterial colonies were counted.
Scanning electron microscopy (SEM). After the preparation of the bacterial cultures in a similar protocol as antimicrobial measurements [35, 36] , the suspensions were added to 10-mL cultures, resulting in final MIC. Control culture was conducted in the absence of tested compound. The suspensions were incubated at 37°C with shaking at 198 rpm. After the period of time incubation according to the results of time-kill assay, the suspensions were centrifuged and discarded the supernatants. The bacterial palette was fixed with glutaraldehyde (50 lL of 2.5%) for 5 min. at 37°C and washed three times with 1X PBS. Finally, 50 lL PBS was added to the bacterial palette to form a suspension. One drop of fixed pallet was transferred on a glass plate and dried at room temperature. Then, the samples were coated with gold and used for observation in a SEM system (Hitachi, 4200) [37] .
Results and Discussion

Chemistry.
The synthetic route for sila-substituted 1,2,3-triazole derivatives is illustrated in Scheme 1. The 1,3-dipolar cycloaddition reaction of benzyl halides, sodium azide and propargyl alcohol was carried out in the presence of CuSO 4 .5H 2 O and sodium ascorbate in t-butyl alcohol and water (1:2) at room temperature to afford the corresponding 1,4-disubstituted-1,2,3-triazoles (1a-i) in high yields. Recently, a variety of organosilicon-sulphur compounds were prepared in our laboratory [38, 39] . The tris(organosilyl)methyllithium compounds were prepared using the published methodologies [40] . Bromomethyl derivatives were synthesized using phosphorus tribromide (PBr 3 ) in dichloromethane at room temperature [41] . Finally, the reaction of tris(trimethylsilyl)methyllithium and carbon disulphide with bromomethyl derivatives was followed in THF at 0 and À46°C for synthesis of sila-thioalkynetriazole (3a-i) and sila-mercapto-thionetriazole (4a-i) analogues, respectively, in excellent yields [23] .
Biological evaluation.
Antiproliferative activity. The synthesized compounds (STATs (3a-i) and SMTTs (4a-4i)) were evaluated for their cytotoxic activity against human breast cancer cell line MCF-7 using standard MTT assay. The cell viability inhibition (IC 50 ) values of these compounds are shown in fig. 1 . A positive control containing doxorubicin drug was also tested as a reference drug for comparison. More than 90% of studied compounds represented a considerable inhibitory effect on the cell proliferation MCF-7. Among which the compounds 3a, 4a and 4e had an excellent cytotoxic activity with IC 50 values of 35.17, 32.63 and 30.3 lg/mL, respectively (table 2). The structure-activity relationships (SAR) study demonstrated that the aryl-substituted 1,2,3-triazoles (3a-g and 4a-g) exhibited better antiproliferative activity (IC 50 values in the range of 35 to 62 lg/mL) than the alkyl-substituted 1,2,3-triazole analogues (3h and 3i and 4h and 4i) with IC 50 values in the range of 125 to 250 lg/mL. In addition to, sila-substituted compounds (3b and 4b) with halogen substituents in the 2-position of the phenyl ring exhibited better cytotoxic activity (35.32 lg/mL) than 4-nitro, 4-bromo-substituted triorganosilyl derivatives (3f and 3g and 4f and 4g) with IC 50 at 62 lg/mL. The extension of the length of carbon tether between the triazole ring and benzene ring in mercapto-thione triorganosilyl analogue resulted in a significant enhancement in their cytotoxic activity. It is noteworthy that 4e without any functional group in the aryl ring exhibited significant enhancement in their cytotoxic activity and inhibition cell growth at IC 50 values of 30.3 lg/mL. This activity was attributed to the favoured interactions between the hydrogenbond acceptor of 4e and its molecular targets. Therefore, the electronic effect and position of the substituent on the phenyl group and ring of triazole had a significant effect on their cytotoxic activity.
Apoptosis assays.
The process of apoptosis or programmed cell death is characterized by a number of distinctive morphological and metabolic changes mediated by a series of gene regulation and cell signalling pathways [42] . The compounds 3a, 4a, and 4e were selected for the further investigations due to their excellent inhibitory effects on the cell proliferation. To explore cytotoxicity of 3a, 4a and 4e compounds in MCF-7 cells, the Scheme 1. General synthesis of triorganosilyl-substituted 1,2,3-triazoles [23] (3a, 3b, 3c, 3d, 3e, 3f, 3g, 3h and 3i and 4a, 4b, 4c, 4d 3 CLi, CS 2 , THF, 0°C; and (iv) (Me 3 Si) 3 CLi, CS 2 , THF, À46°C. apoptotic morphology of cells was investigated by DAPI staining approach. Chromatin morphological changes of healthy as well as apoptotic cells were studied. As shown in fig. 2 , the untreated control MCF-7 cells showed normal round nuclei, that is no apoptosis of cancer cell nucleus, whereas STATand SMTT-treated cells showed fragmented or damaged apoptotic nuclei, which is comparable to the apoptosis induced by standard doxorubicin (fig. 2) .
Cell cycle analysis.
Flow cytometry was performed using PI for evaluation of the influence of STAT (3a), SMTT (4a) and SMTT (4e) on cell cycle progression. MCF-7 cells were cultivated, next treated with 20, 31 and 62 lg/mL of each compound, and then the cells were harvested and analysed after 48 hr. The results indicated that the percentage of apoptotic cells increased in a dose-dependent manner. The cells treated with 20 or 31 lg/ mL of 3a compound showed no significant effect on cell cycle as compared to control, but at a higher dose (62 lg/mL), the percentage of cells in G0/G1 increased (86.54%) as compared to lower doses (67.60% or 67.36%) which is along with a significant decrease in the percentage of S-phase cells from 26.60% or 25.97% to 6.79% (p < 0.05) (fig. 3A) . The results of 4e compound are similar to 3a; that is, the cells showed no significant effects in low doses, while the majority of the cells were in G0/G1 phase in higher dose (62 lg/mL) ( fig. 3B) . Especially in the case of compound 4a, a cell cycle arrest was observed in G1 at 100 lg/mL ( fig. 3C ). Effect on the mRNA expression of Bcl-2 and cyclin D1. The gene bcl-2 is an anti-apoptotic protein with apoptosisblocking properties [43] . Cyclin D1 is expressed in breast cancer cell lines at high levels [44] , as well as a director of cell cycle and necessary for progression of G0 in to S phase. In this work, the expression of both Bcl-2 and cyclin D1 was studied to evaluate the cytotoxic effects of our compounds on gene expression levels from apoptotic or cell cycle points of view. The qRT-PCR results exhibited a down-regulation in the transcription and expression of Bcl-2 mRNA, which prevents entering of the cells to apoptosis ( fig. 4 ), highest reduction levels were for 3a and 4e (p < 0.001) and a bit lower reduction for 4a (p < 0.01) (fig. 4) . Similarly, the expression of cyclin D1 also significantly decreased by the cells treated with 4e (p < 0.05), 4a (p < 0.01) and 3a (p < 0.001) (fig. 4 ). These results highlighted the possible potential of 4e, 4a and 3a in disturbing cell cycle progression and direction of cells to apoptosis. The DNJ/triazole mix showed a reduction in cyclin D1 expression [45] , and as this compound is similar to ours, it is probable to observe decreased levels of cyclin D1 by the compounds 4e, 4a and 3a as well. The curcumin hybrids of triazole also showed reduction of Bcl-2 gene expression [46] which is in line with our study showing significant down-regulation of Bcl-2 by 4a, 4e and 3a compounds of triazole.
Antimicrobial activity and minimum inhibitory concentration values.
The synthesized compounds (STATs (3a-i) and SMTTs (4a-i)) were evaluated for their antimicrobial activities against P. aeruginosa, S. aureus, A. baumannii, E. faecium and E. faecalis bacteria. The results are summarized in fig. 5 . The sila-substituted thioalkyne 1,2,3-triazoles 3a-i exhibited effective antimicrobial activity against all of the tested bacterial strains except P. aeruginosa. Especially, 3e showed promising antibacterial activity with the MIC value from 15 to 62 lg/mL against tested bacterial strains. On the other hand, the sila-substituted mercapto-thione 1,2,3-triazoles (4a-i) showed only antibacterial activity against gram-positive strains. It was found that the antimicrobial activity of aryl-substituted 1,2,3-triazoles were better than that of the alkyl-substituted 1,2,3-triazoles in both series of STATs and SMTTs. The effect of alkyl chain length on the antibacterial activities showed that the activity was improved for compounds 3i and 4i containing long alkyl chains. According to the MIC value results, introduction of electron withdrawing groups such as chloro, bromo and nitro on the phenyl ring as in 3b, 3d, 3f and 3g and 4b, 4d, 4f and 4g led to a decrease in antibacterial activity. Based on the results of antibacterial activity and the MIC value, 3e from STATs series and 4e from SMTTs series were chosen for subsequent experiment in a time-kill study and also the observations in the SEM studies.
Time-kill study.
The time-kill assay was performed for the evaluation of the antimicrobial efficiency of sila-organosulphur 1,2,3-triazoles (STAT 3e and SMTT 4e) against gram-positive S. aureus ( fig. 6A , B) and gram-negative A. baumannii ( fig. 6C ). The bacterial cultures were exposed to the tested compounds (MIC and 2 9 MIC) at time points 0, 5, 15, 30, 90, 180 and 240 min. and 6, 8 and 12 hr, respectively. As fig. 6 demonstrates, the derivative 3e from the STAT series showed high killing efficiency for both microorganisms in <90 min. for S. aureus and within 180 min. for A. baumannii. The killing rate of 3e increased for both strains to <30 min. at the 29 MIC value. Derivative 4e of the SMTT series required 6 hr to completely eliminate S. aureus strain. On the other hand, the killing efficacy of 4e against the S. aureus strain was improved at 29 MIC value and 100% killing was observed within 240 min. The derivative 3e from the STAT series was more efficient than the derivative 4e from the SMTT series and the great ratio of the bacterial cell death was observed at only 30 min., indicating that the thioalkyne groups play a significant role in antibacterial activity. These results suggest that the STAT and SMTT series compounds are bactericidal but the rate of killing varies.
Electron microscope observation.
The electron micrographs by SEM of A. baumannii and S. aureus cells untreated and treated with the tested compounds at MIC are shown in fig. 7 . The important morphological changes on the surface of the treated strains are found compared with the untreated controls. The surface of the untreated cells was smooth, regular, rod shape and intact, while the cells treated with tested compounds were severely damaged. 
Conclusion
In conclusion, a series of new sila-organosulphur compounds containing 1,2,3-triazole moieties (3a-i and 4a-i) were prepared and evaluated for their in vitro cytotoxicity potential against breast tumour cells of MCF-7. The results showed clearly that compound 3a from series sila-substituted thioalkyne 1,2,3-triazoles (STATs) and the compounds 4a and 4e from series sila-substituted mercapto-thione 1,2,3-triazoles (SMTTs) exhibited excellent growth inhibition against MCF-7 with IC 50 values of 35.17, 32.63 and 30.3 lg/mL, respectively. It was found that their activities are comparable to the standard anticancer drug doxorubicin. Flow cytometry analysis revealed that there was possibly G1 cell cycle arrest. The results of DAPI staining and qRT-PCR indicated the possible potential of 3a, 4a and 4e in disturbing cell cycle progression and direction of cells to apoptosis. In addition, both the STAT and SMTT families represent a novel class of highly effective antibacterial organometallic compounds. Especially, the compounds 3e and 4e showed the most effective antibacterial activities. The results of the time-kill assay suggest that the STAT and SMTT series compounds are bactericidal but the rate of killing varies. Although morphological changes of the gram-negative A. baumannii and gram-positive S. aureus strains were studied, further research of the mechanism should be carried out in the future. The significant antibacterial and anticancer activity of the synthesized compounds highlight them as promising molecules for the development of highly specific antibacterial/anticancer agents -in other words, incorporating both properties in the same molecule.
